• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

节约开关。

The saving switch.

出版信息

Nat Med. 2010 Jan;16(1):18-21. doi: 10.1038/nm0110-18.

DOI:10.1038/nm0110-18
PMID:20057412
Abstract

The epigenome consists of a system of chemical tags that attach to our DNA and its associated molecules, switching genes on and off. But the system is not without glitches-and scientists think that the misplacement of these tags can cause disease. This idea has led to new drugs that aim to correct gene activity (and obliterate disease) by altering the proteins around which DNA winds. Cassandra Willyard examines whether this approach will unlock the long-awaited promise of epigenetic therapy.

摘要

表观基因组由一套化学标记组成,这些标记附着在我们的 DNA 及其相关分子上,开启和关闭基因。但这个系统并非完美无缺——科学家认为,这些标记的错位可能导致疾病。这一观点催生了旨在通过改变 DNA 缠绕的蛋白质来修正基因活性(并消除疾病)的新药。Cassandra Willyard 探讨了这种方法是否能兑现人们对表观遗传学治疗法的殷切期望。

相似文献

1
The saving switch.节约开关。
Nat Med. 2010 Jan;16(1):18-21. doi: 10.1038/nm0110-18.
2
Histone deacetylase inhibitors sit at crossroads of diet, aging, cancer.组蛋白去乙酰化酶抑制剂处于饮食、衰老和癌症的交叉点。
J Natl Cancer Inst. 2006 Mar 15;98(6):377-9. doi: 10.1093/jnci/djj120.
3
New clinical developments in histone deacetylase inhibitors for epigenetic therapy of cancer.组蛋白去乙酰化酶抑制剂在癌症表观遗传学治疗中的新临床进展。
J Hematol Oncol. 2009 Jun 1;2:22. doi: 10.1186/1756-8722-2-22.
4
Vorinostat, SAHA, represses telomerase activity via epigenetic regulation of telomerase reverse transcriptase in non-small cell lung cancer cells.伏立诺他、SAHA 通过端粒酶逆转录酶的表观遗传调控抑制非小细胞肺癌细胞中端粒酶活性。
J Cell Biochem. 2011 Oct;112(10):3044-53. doi: 10.1002/jcb.23229.
5
Combined inhibition of EZH2 and histone deacetylases as a potential epigenetic therapy for non-small-cell lung cancer cells.EZH2与组蛋白去乙酰化酶的联合抑制作为非小细胞肺癌细胞的一种潜在表观遗传疗法。
Cancer Sci. 2016 Jul;107(7):955-62. doi: 10.1111/cas.12957. Epub 2016 Jun 13.
6
Intracellular vorinostat accumulation and its relationship to histone deacetylase activity in soft tissue sarcoma patients.软组织肉瘤患者细胞内伏立诺他蓄积及其与组蛋白脱乙酰酶活性的关系。
Cancer Chemother Pharmacol. 2017 Aug;80(2):433-439. doi: 10.1007/s00280-017-3357-y. Epub 2017 Jun 13.
7
DNA microarray profiling of genes differentially regulated by the histone deacetylase inhibitors vorinostat and LBH589 in colon cancer cell lines.应用 DNA 微阵列技术分析组蛋白去乙酰化酶抑制剂伏立诺他和 LBH589 调控结肠癌细胞系差异表达基因的表达谱。
BMC Med Genomics. 2009 Nov 30;2:67. doi: 10.1186/1755-8794-2-67.
8
HDAC inhibitors: magic bullets, dirty drugs or just another targeted therapy.组蛋白去乙酰化酶抑制剂:神奇子弹、有害药物还是仅仅是另一种靶向治疗?
Cancer Lett. 2009 Aug 8;280(2):123-4. doi: 10.1016/j.canlet.2009.02.038. Epub 2009 Mar 19.
9
Effect of C7-substitution of 1-arylsulfonyl-5-(N-hydroxyacrylamide)indolines on the selectivity towards a subclass of histone deacetylases.1-芳磺酰基-5-(N-羟基丙烯酰胺)吲哚啉 C7 取代物对组蛋白去乙酰化酶亚类选择性的影响。
Org Biomol Chem. 2014 Nov 28;12(44):8966-76. doi: 10.1039/c4ob00542b.
10
Tissue transglutaminase (TG2) is involved in the resistance of cancer cells to the histone deacetylase (HDAC) inhibitor vorinostat.组织转谷氨酰胺酶(TG2)参与癌细胞对组蛋白脱乙酰酶(HDAC)抑制剂伏立诺他的耐药过程。
Amino Acids. 2017 Mar;49(3):517-528. doi: 10.1007/s00726-016-2338-5. Epub 2016 Oct 19.

引用本文的文献

1
Does epigenetics have a role in age related macular degeneration and diabetic retinopathy?表观遗传学在年龄相关性黄斑变性和糖尿病视网膜病变中起作用吗?
Genes Dis. 2020 Jan 23;8(3):279-286. doi: 10.1016/j.gendis.2020.01.003. eCollection 2021 May.
2
Epigenetic modifications in hyperhomocysteinemia: potential role in diabetic retinopathy and age-related macular degeneration.高同型半胱氨酸血症中的表观遗传修饰:在糖尿病视网膜病变和年龄相关性黄斑变性中的潜在作用。
Oncotarget. 2018 Jan 29;9(16):12562-12590. doi: 10.18632/oncotarget.24333. eCollection 2018 Feb 27.
3
Epigenetic modifications: basic mechanisms and role in cardiovascular disease.

本文引用的文献

1
The HDAC inhibitor 4b ameliorates the disease phenotype and transcriptional abnormalities in Huntington's disease transgenic mice.组蛋白去乙酰化酶抑制剂4b可改善亨廷顿舞蹈病转基因小鼠的疾病表型和转录异常。
Proc Natl Acad Sci U S A. 2008 Oct 7;105(40):15564-9. doi: 10.1073/pnas.0804249105. Epub 2008 Sep 30.
2
Drug sensitivity prediction by CpG island methylation profile in the NCI-60 cancer cell line panel.基于NCI-60癌细胞系面板中CpG岛甲基化谱的药物敏感性预测
Cancer Res. 2007 Dec 1;67(23):11335-43. doi: 10.1158/0008-5472.CAN-07-1502.
3
Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer.
表观遗传修饰:基本机制及其在心血管疾病中的作用
Circulation. 2011 May 17;123(19):2145-56. doi: 10.1161/CIRCULATIONAHA.110.956839.
4
Epigenetic modulation of the renal β-adrenergic-WNK4 pathway in salt-sensitive hypertension.盐敏感性高血压中肾脏β-肾上腺素能-WNK4 途径的表观遗传调控。
Nat Med. 2011 May;17(5):573-80. doi: 10.1038/nm.2337. Epub 2011 Apr 17.
5
[Epigentics in rheumatic diseases].[风湿性疾病中的表观遗传学]
Z Rheumatol. 2011 Apr;70(3):205-8, 210-2. doi: 10.1007/s00393-010-0689-y.
6
HDAC inhibition in lupus models.在狼疮模型中抑制组蛋白去乙酰化酶。
Mol Med. 2011 May-Jun;17(5-6):417-25. doi: 10.2119/molmed.2011.00055. Epub 2011 Feb 11.
7
The epigenomic interface between genome and environment in common complex diseases.常见复杂疾病中基因组与环境的表观基因组界面。
Brief Funct Genomics. 2010 Dec;9(5-6):477-85. doi: 10.1093/bfgp/elq026. Epub 2010 Nov 8.
组蛋白H4赖氨酸16位乙酰化缺失和赖氨酸20位三甲基化是人类癌症的常见特征。
Nat Genet. 2005 Apr;37(4):391-400. doi: 10.1038/ng1531. Epub 2005 Mar 13.
4
Role of thioredoxin in the response of normal and transformed cells to histone deacetylase inhibitors.硫氧还蛋白在正常细胞和转化细胞对组蛋白去乙酰化酶抑制剂反应中的作用。
Proc Natl Acad Sci U S A. 2005 Jan 18;102(3):673-8. doi: 10.1073/pnas.0408732102. Epub 2005 Jan 6.
5
Reprogramming of a melanoma genome by nuclear transplantation.通过核移植对黑色素瘤基因组进行重编程。
Genes Dev. 2004 Aug 1;18(15):1875-85. doi: 10.1101/gad.1213504.
6
Transcriptional signature of histone deacetylase inhibition in multiple myeloma: biological and clinical implications.组蛋白去乙酰化酶抑制在多发性骨髓瘤中的转录特征:生物学及临床意义
Proc Natl Acad Sci U S A. 2004 Jan 13;101(2):540-5. doi: 10.1073/pnas.2536759100. Epub 2003 Dec 26.
7
Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila.组蛋白去乙酰化酶抑制剂可阻止果蝇中多聚谷氨酰胺依赖性神经变性。
Nature. 2001 Oct 18;413(6857):739-43. doi: 10.1038/35099568.
8
A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases.一类转化细胞分化的杂交极性诱导剂可抑制组蛋白脱乙酰基酶。
Proc Natl Acad Sci U S A. 1998 Mar 17;95(6):3003-7. doi: 10.1073/pnas.95.6.3003.
9
Second generation hybrid polar compounds are potent inducers of transformed cell differentiation.第二代杂化极性化合物是转化细胞分化的有效诱导剂。
Proc Natl Acad Sci U S A. 1996 Jun 11;93(12):5705-8. doi: 10.1073/pnas.93.12.5705.
10
Hemoglobin synthesis in murine virus-induced leukemic cells in vitro: stimulation of erythroid differentiation by dimethyl sulfoxide.体外小鼠病毒诱导白血病细胞中的血红蛋白合成:二甲基亚砜对红系分化的刺激作用
Proc Natl Acad Sci U S A. 1971 Feb;68(2):378-82. doi: 10.1073/pnas.68.2.378.